NAUT
Price
$0.70
Change
-$0.01 (-1.41%)
Updated
May 9 closing price
Capitalization
88.3M
87 days until earnings call
RGLS
Price
$7.87
Change
+$0.02 (+0.25%)
Updated
May 9 closing price
Capitalization
544.53M
94 days until earnings call
Ad is loading...

NAUT vs RGLS

Header iconNAUT vs RGLS Comparison
Open Charts NAUT vs RGLSBanner chart's image
Nautilus Biotechnolgy
Price$0.70
Change-$0.01 (-1.41%)
Volume$105.79K
Capitalization88.3M
Regulus Therapeutics
Price$7.87
Change+$0.02 (+0.25%)
Volume$1.65M
Capitalization544.53M
NAUT vs RGLS Comparison Chart
Loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAUT vs. RGLS commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAUT is a Hold and RGLS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (NAUT: $0.70 vs. RGLS: $7.87)
Brand notoriety: NAUT and RGLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAUT: 63% vs. RGLS: 70%
Market capitalization -- NAUT: $88.3M vs. RGLS: $544.53M
NAUT [@Biotechnology] is valued at $88.3M. RGLS’s [@Biotechnology] market capitalization is $544.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAUT’s FA Score shows that 1 FA rating(s) are green whileRGLS’s FA Score has 0 green FA rating(s).

  • NAUT’s FA Score: 1 green, 4 red.
  • RGLS’s FA Score: 0 green, 5 red.
According to our system of comparison, RGLS is a better buy in the long-term than NAUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAUT’s TA Score shows that 6 TA indicator(s) are bullish while RGLS’s TA Score has 4 bullish TA indicator(s).

  • NAUT’s TA Score: 6 bullish, 2 bearish.
  • RGLS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NAUT is a better buy in the short-term than RGLS.

Price Growth

NAUT (@Biotechnology) experienced а +3.34% price change this week, while RGLS (@Biotechnology) price change was +0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

NAUT is expected to report earnings on Aug 05, 2025.

RGLS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGLS($545M) has a higher market cap than NAUT($88.3M). RGLS YTD gains are higher at: 398.101 vs. NAUT (-58.333). RGLS has higher annual earnings (EBITDA): -45.85M vs. NAUT (-75.12M). NAUT has more cash in the bank: 130M vs. RGLS (75.8M). RGLS has less debt than NAUT: RGLS (274K) vs NAUT (30.5M). NAUT (0) and RGLS (0) have equivalent revenues.
NAUTRGLSNAUT / RGLS
Capitalization88.3M545M16%
EBITDA-75.12M-45.85M164%
Gain YTD-58.333398.101-15%
P/E RatioN/AN/A-
Revenue00-
Total Cash130M75.8M172%
Total Debt30.5M274K11,131%
FUNDAMENTALS RATINGS
NAUT vs RGLS: Fundamental Ratings
NAUT
RGLS
OUTLOOK RATING
1..100
5231
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
10081
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
9334
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (14) in the null industry is somewhat better than the same rating for RGLS (61) in the Pharmaceuticals Other industry. This means that NAUT’s stock grew somewhat faster than RGLS’s over the last 12 months.

RGLS's Profit vs Risk Rating (81) in the Pharmaceuticals Other industry is in the same range as NAUT (100) in the null industry. This means that RGLS’s stock grew similarly to NAUT’s over the last 12 months.

NAUT's SMR Rating (96) in the null industry is in the same range as RGLS (98) in the Pharmaceuticals Other industry. This means that NAUT’s stock grew similarly to RGLS’s over the last 12 months.

RGLS's Price Growth Rating (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for NAUT (93) in the null industry. This means that RGLS’s stock grew somewhat faster than NAUT’s over the last 12 months.

RGLS's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as NAUT (100) in the null industry. This means that RGLS’s stock grew similarly to NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAUTRGLS
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
74%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-2.03%
FHTX - NAUT
51%
Loosely correlated
-7.28%
KYMR - NAUT
48%
Loosely correlated
-2.27%
TECH - NAUT
46%
Loosely correlated
+0.32%
IMNM - NAUT
45%
Loosely correlated
-3.24%
NRIX - NAUT
45%
Loosely correlated
-1.45%
More

RGLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGLS has been loosely correlated with ABEO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RGLS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
+0.25%
ABEO - RGLS
42%
Loosely correlated
-4.01%
NKTX - RGLS
32%
Poorly correlated
-1.03%
NAUT - RGLS
31%
Poorly correlated
-2.03%
ATOS - RGLS
31%
Poorly correlated
+0.85%
XENE - RGLS
30%
Poorly correlated
-1.46%
More